BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
PPARA
,
Angiogenesis
,
Influenza
,
Liver
,
Personalized medicine
,
Valproic acid
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nuclear import signal receptor activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Stomach cardiac
Trachea
Kidney cortex
Duodenum
Testes
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Varicella-zoster virus infection
Multiple-resistant Staphylococcus aureus infection
Duchenne muscular dystrophy
Bacterial pneumonia
Abscess
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
combretastatin A-4
Apitolisib
NVP-AEW541
PD 184352
HG-14-10-04
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
DYNLT3
TAL2
PLXNA1
IRF7
CRKL
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for nuclear import signal receptor activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand …
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
New Signaling Pathway Targeting Systemic Lupus Erythematosus
Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ